EDSA
EDSA
NASDAQ · Biotechnology

Edesa Biotech Inc

$1.88
-0.20 (-9.62%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +1,503.2% upside
Low Target $22.58
Average Target $30.14
High Target $41.69
Current Price $1.88
Current
$1.88
Target
$30.14
$22.58 $30.14 avg $41.69
Scenario Analysis
Bear Case
$22.58
1,101.1%
Low target
Base Case
$30.14
+1,503.2%
Avg target
Bull Case
$41.69
+2,117.6%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$20.32
-90.7% from high
52-Week Low
$0.72
+161.1% from low
Target vs 52W High
$30.14
+48.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.4%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.5%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%